Cargando…

Structural insights into the Omicron spike trimer: tackling the challenges of continuously evolving SARS-CoV-2 variants

Detalles Bibliográficos
Autores principales:	Ou, Junxian, Wu, Jianguo, Zhang, Qiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481628/ https://www.ncbi.nlm.nih.gov/pubmed/36114171 http://dx.doi.org/10.1038/s41392-022-01179-5

Ejemplares similares

Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
por: Odak, Ivan, et al.
Publicado: (2022)

Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
por: Ou, Junxian, et al.
Publicado: (2022)

Mutated trimeric RBD vaccines: a platform against variants of concern
por: Aparicio, Belén, et al.
Publicado: (2023)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

The continuously evolving CRISPR barcoding toolbox
por: Gaj, Thomas, et al.
Publicado: (2018)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

Evergreen influenza – Tackling an old enemy with fresh munitions
por: Häfner, Sophia Julia
Publicado: (2019)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Sweet dreams: How mini-invasive surgery tackles obstructive sleep apnea
por: Häfner, Sophia Julia
Publicado: (2019)

Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
por: Wang, Jiayu, et al.
Publicado: (2022)

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
por: Marcotte, Harold, et al.
Publicado: (2022)

Kicking KRAS to tackle lung cancer
por: Abbott, Ben
Publicado: (2021)

Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain
por: Ribes, Marta, et al.
Publicado: (2021)

Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer
por: Zhan, Wuqiang, et al.
Publicado: (2022)

Highlight—Tracking Adaptation's Role: Do Larger Populations Evolve Faster?
por: Venton, Danielle
Publicado: (2012)

Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection
por: Wu, Yan, et al.
Publicado: (2022)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle
por: Popowicz, Grzegorz Maria, et al.
Publicado: (2022)

Cultivating Yet-to-be Cultivated Microbes: The Challenge Continues
por: Narihiro, Takashi, et al.
Publicado: (2013)

The SARS-CoV-2 spike protein: balancing stability and infectivity
por: Berger, Imre, et al.
Publicado: (2020)

Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection
por: Kalra, Rajkumar Singh, et al.
Publicado: (2021)

Evolving as a holobiont
por: Richardson, Lauren A.
Publicado: (2017)

Omicron, the great escape artist
por: Flemming, Alexandra
Publicado: (2022)

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
por: Chen, Shiqi, et al.
Publicado: (2023)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
por: Wang, Xinling, et al.
Publicado: (2023)

Cap snatch prevention: a novel approach to tackle influenza viruses
por: Sparrer, Konstantin M. J., et al.
Publicado: (2023)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

SARS-CoV-2 Variants of Concern Delta: a great challenge to prevention and control of COVID-19
por: Li, Maochen, et al.
Publicado: (2021)

Omicron: increased transmissibility and decreased pathogenicity
por: Bálint, Gábor, et al.
Publicado: (2022)

Up or down: where comes Omicron?
por: Liu, Zezhong, et al.
Publicado: (2022)

Birds, blooms, and evolving diversity
por: Richardson, Lauren A.
Publicado: (2018)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
por: Wang, Yingdan, et al.
Publicado: (2022)

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
por: Li, Maochen, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: flexibility as a new target for fighting infection
por: Pierri, Ciro Leonardo
Publicado: (2020)

Stabilizing the closed SARS-CoV-2 spike trimer
por: Juraszek, Jarek, et al.
Publicado: (2021)

A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants
por: Wang, Rui, et al.
Publicado: (2022)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61d54igthlpvd2ct0mi6rs5cau